Cue Biopharma Inc. (CUE)
NASDAQ: CUE
· Real-Time Price · USD
0.81
0.02 (2.53%)
At close: Aug 15, 2025, 3:59 PM
0.83
2.48%
After-hours: Aug 15, 2025, 06:54 PM EDT
Cue Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8.29M | 7.99M | 9.29M | 9.53M | 8.3M | 7.02M | 5.49M | 3.82M | 1.79M | 432.23K | 1.25M | 9.35M | 11.68M | 14.39M | 14.94M | 7.16M | 5.47M | 3.81M |
Cost of Revenue | n/a | n/a | 849K | 1.7M | 37.22M | 38.07M | 38.1M | 37.83M | 2.85M | 2.46M | 1.81M | 7.91M | 18.66M | 26.97M | 36.55M | 43.01M | 37.79M | 37.14M |
Gross Profit | 5.33M | 7.99M | 9.29M | 8.68M | -28.07M | -30.2M | -32.61M | -34.01M | -1.06M | -2.02M | -560.83K | 1.44M | -6.99M | -12.58M | -21.61M | -35.85M | -32.32M | -33.34M |
Operating Income | -39.38M | -41.13M | -41.5M | -45.54M | -48.15M | -51.28M | -51.99M | -53.18M | -52.79M | -52.37M | -53.22M | -46.25M | -48.24M | -45.45M | -43.73M | -46.81M | -43.93M | -44.57M |
Interest Income | 1M | 1.23M | 1.62M | 2.24M | 2.59M | 2.73M | 2.81M | 2.54M | 2.04M | 1.56M | 928.24K | 299.9K | 124.9K | 60.9K | 65.9K | 65.91K | 163.91K | 273.91K |
Pretax Income | -38.9M | -40.58M | -40.67M | -44.61M | -46.96M | -49.97M | -50.73M | -51.89M | -51.84M | -51.86M | -53.01M | -46.31M | -48.35M | -45.42M | -43.67M | -46.67M | -43.71M | -44.27M |
Net Income | -38.9M | -40.58M | -40.67M | -44.61M | -46.96M | -49.97M | -50.83M | -51.85M | -51.73M | -51.87M | -52.93M | -46.86M | -48.98M | -45.93M | -44.16M | -46.88M | -43.92M | -44.47M |
Selling & General & Admin | 14.74M | 14.57M | 13.74M | 13.57M | 14.35M | 15.09M | 15.93M | 15.77M | 15.66M | 15.19M | 16.17M | 17.19M | 17.76M | 18.26M | 17.36M | 16.16M | 15.35M | 14.94M |
Research & Development | 33.02M | 34.64M | 36.29M | 39.9M | 40.39M | 41.51M | 40.7M | 41.25M | 38.94M | 37.89M | 38.58M | 38.75M | 42.46M | 41.63M | 41.37M | 37.87M | 34.1M | 33.46M |
Other Expenses | 4K | 4K | 853K | 849K | -8K | -8K | -857K | -857K | n/a | n/a | n/a | -25K | n/a | n/a | n/a | 25K | -23K | -48K |
Operating Expenses | 47.77M | 49.22M | 50.88M | 54.32M | 54.73M | 56.59M | 55.77M | 56.16M | 54.6M | 53.08M | 54.75M | 55.86M | 60.17M | 59.84M | 58.67M | 53.97M | 49.4M | 48.37M |
Interest Expense | 424K | 684K | 797K | 1.15M | 1.25M | 1.27M | 1.4M | 1.25M | 1.08M | 1.06M | 713.82K | 356K | 232K | 26K | 1K | n/a | 23K | 48K |
Selling & Marketing Expenses | n/a | n/a | -849K | -1.6M | -1.6M | -1.6M | -751K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.08M | 49.12M | 50.79M | 55.07M | 56.44M | 58.3M | 57.48M | 57.02M | 54.6M | 53.08M | 54.75M | 55.86M | 60.17M | 59.84M | 58.67M | 53.97M | 49.4M | 48.37M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 99K | -39.43K | -115.43K | 2.57K | -79.43K | 554K | 632K | 514K | 497K | 208.25K | 206.25K | 206.25K |
Shares Outstanding (Basic) | 95.46M | 74.25M | 74.24M | 51.23M | 50.17M | 49.47M | 47.14M | 46.36M | 44.8M | 44.65M | 39.17M | 35.38M | 35.36M | 32.64M | 31.52M | 31.32M | 31.23M | 30.43M |
Shares Outstanding (Diluted) | 95.46M | 74.25M | 74.24M | 51.23M | 50.17M | 49.47M | 47.14M | 46.36M | 44.8M | 44.65M | 39.17M | 35.38M | 35.36M | 32.64M | 31.52M | 31.32M | 31.23M | 30.43M |
EPS (Basic) | -0.56 | -0.67 | -0.75 | -0.9 | -0.97 | -1.06 | -1.11 | -1.2 | -1.27 | -1.36 | -1.5 | -1.4 | -1.5 | -1.45 | -1.42 | -1.52 | -1.45 | -1.5 |
EPS (Diluted) | -0.56 | -0.67 | -0.75 | -0.9 | -0.97 | -1.06 | -1.11 | -1.2 | -1.27 | -1.36 | -1.5 | -1.4 | -1.5 | -1.45 | -1.42 | -1.52 | -1.45 | -1.5 |
EBITDA | -36.82M | -37.27M | -37.28M | -40.02M | -42.28M | -45.3M | -45.9M | -47.48M | -47.91M | -48.35M | -50.49M | -46.66M | -49.05M | -46.47M | -44.66M | -45.55M | -42.74M | -43.44M |
EBIT | -29.94M | -39.9M | -39.88M | -43.46M | -45.71M | -48.7M | -49.34M | -50.64M | -50.76M | -50.81M | -52.3M | -45.96M | -48.12M | -45.4M | -43.67M | -46.75M | -43.89M | -44.55M |
Depreciation & Amortization | 1.86M | 2.73M | 2.69M | 3.44M | 3.42M | 3.4M | 3.44M | 3.17M | 2.85M | 2.46M | 1.81M | -1.5M | -1.72M | -1.87M | -1.78M | 1.2M | 1.15M | 1.11M |